The newest aging brain research from the University of California, San Francisco points to a single protein that may be pushing the hippocampus toward decline. In mice, that protein, FTL1, was tied to fewer neuron connections, weaker performance on cognitive tests, and clear signs of age-related change in the brain. Researchers also found that lowering FTL1 in older mice was linked to recovery in memory and brain-cell connections.
What the UCSF team found in the aging brain
Scientists at UCSF tracked changes in genes and proteins in the hippocampus over time, focusing on the part of the brain central to learning and memory. Among the shifts they examined, FTL1 stood out as the one protein that was consistently different between young and old animals. Older mice had higher levels of FTL1, while also showing fewer connections between neurons in the hippocampus and poorer cognitive performance.
When the team raised FTL1 levels in young mice, the effect moved in the opposite direction. Their brains began to look and function more like those of older mice, and their behavior changed to match that shift. In lab experiments, nerve cells engineered to produce high amounts of FTL1 developed simplified structures, forming short, single extensions instead of the complex branching networks seen in healthier cells.
Why reducing FTL1 mattered
The most striking result came when researchers lowered FTL1 in older mice. The animals showed clear signs of recovery, with more connections between brain cells and better performance on memory tests. Saul Villeda, PhD, associate director of the UCSF Bakar Aging Research Institute and senior author of the paper published in Nature Aging, said, “It is truly a reversal of impairments. It’s much more than merely delaying or preventing symptoms. ”
The study also linked FTL1 to how brain cells use energy. In older mice, higher levels of the protein slowed cellular metabolism in the hippocampus. When researchers treated those cells with a compound that boosts metabolism, the negative effects were prevented. That finding gives the work a second path of interest: not only the protein itself, but the energy changes tied to it.
Immediate reaction and wider significance
Villeda said the findings could help point toward treatments that target FTL1 and counter its effects in the brain. He added, “We’re seeing more opportunities to alleviate the worst consequences of old age. It’s a hopeful time to be working on the biology of aging. ” The study was funded in part by the Simons Foundation, Bakar Family Foundation, National Science Foundation, Hillblom Foundation, Bakar Aging Research Institute, Marc and Lynne Benioff, and the National Institutes of Health.
This aging brain work is focused on mice, so the results do not yet show how the same process may work in people. Still, the study adds a sharp new candidate to the search for what drives hippocampal decline and what might reverse it.
What comes next for aging brain research
The immediate next step is clear: test whether the same FTL1 pattern appears in broader settings and whether the metabolism link can be turned into a practical treatment route. For now, the aging brain findings point to a measurable protein, a recoverable loss, and a possible way to slow or reverse damage tied to aging brain change.
